Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SSR2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | ALDH1A2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | UFC1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | TIMMDC1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | RHBDL1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | DCAF4L1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | NR6A1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | PIGF | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | PHC3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | NCAM1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |